AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

XAAR PLC

Remuneration Information Nov 3, 2020

4768_dirs_2020-11-03_9de5ff9f-b9f2-444c-9a8e-63df08279c2d.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1121E

Xaar PLC

03 November 2020

Xaar plc (the "Company")

Grant of Options - Sharesave (SAYE)

The Company announces that on 2 November 2020 the following persons discharging managerial responsibilities of the Company were granted share options over ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") under the terms of the 2017 Sharesave Scheme (the "Scheme"), at an exercise price per Ordinary Share of £1.02:

Name Role No. of options* granted over Ordinary Shares Total no. of options** held following grant
John Mills Chief Executive Officer 5,294 550,622
Ian Tichias Chief Finance Officer 5,294 225,294

* Options granted on 2 November 2020 under the Scheme

** Options granted over Ordinary Shares under all schemes

No consideration was paid for the grant of these options.

The options granted under the Scheme are, in normal circumstances, not exercisable until the completion of a 3 year savings period, which will end on 1 December 2023 and will then be exercisable for a period of 6 months. The exercise period will therefore be in normal circumstances, from 1 December 2023 until 31 May 2024.

This notification is made in accordance with DTR 3.1.4 R(1).

Enquiries:

Xaar plc
Ian Tichias

Chief Finance Officer

& Company Secretary
01223 423 663

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHKKNBBDBDDFDK

Talk to a Data Expert

Have a question? We'll get back to you promptly.